2012
DOI: 10.4161/jig.23745
|View full text |Cite
|
Sign up to set email alerts
|

Sacral nerve stimulation in the treatment of fecal incontinence – the experience of a pelvic floor center: Short-term results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
7
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 10 publications
0
7
0
Order By: Relevance
“…The rate of surgical site infection has been reported to be between 1% and 23%. [3][4][5][6][7] Length of time between stages 1 and 2 has not been shown to be predictive of risk of infection. 8 Use of gentamicin-impregnated collagen has been described as a potential method to reduce surgical site infections.…”
mentioning
confidence: 95%
“…The rate of surgical site infection has been reported to be between 1% and 23%. [3][4][5][6][7] Length of time between stages 1 and 2 has not been shown to be predictive of risk of infection. 8 Use of gentamicin-impregnated collagen has been described as a potential method to reduce surgical site infections.…”
mentioning
confidence: 95%
“…VNS was previously shown to suppress colonic inflammation in similar animal models as in this study and to be feasible and effective in treating patients with Crohn's disease . SNS has been reported for the treatment of fecal incontinent, slow transit constipation, and diarrhea‐predominant irritable bowel syndrome and also reported to be useful in improving the symptoms of interstitial cystitis (IC) in human being and in reinforcing rectal epithelial barrier in a porcine model . To the best of our knowledge, there has not been published studies except a clinical case report investigating the anti‐inflammation effect and mechanisms of SNS.…”
Section: Discussionmentioning
confidence: 62%
“…13,15 VNS was previously shown to suppress colonic inflammation in similar animal models as in this study and to be feasible and effective in treating patients with Crohn's disease. 37 SNS has been reported for the treatment of fecal incontinent, slow transit constipation, and diarrhea-predominant irritable bowel syndrome 38 and also reported to be useful in improving the symptoms of interstitial cystitis (IC) in human being [39][40][41] and in reinforcing rectal epithelial barrier in a porcine model. 42 To the best of our knowledge, there has not been published studies except a clinical case Based on the cholinergic anti-inflammatory pathway and the innervation of pelvic splanchnic nerve from the sacral nerve, we hypothesized an anti-inflammatory effect of SNS that might be more potent than VNS for distal colon inflammation since the distal colon is believed to be innervated more densely with sacral nerve than vagus nerve.…”
Section: Effects Of Sns On Intestinal Inflammatory In Dss-treated Ratsmentioning
confidence: 99%
“…One in five people suffer from FGID, and pharmaceutical intervention is often unsuccessful partly due to the lack of fundamental understanding of the colonic ENS [22][23][24][25] . An emerging alternative intervention is peripheral nerve stimulation [26][27][28][29][30] . Sacral nerve stimulation (SNS) in particular has been shown to be an effective therapy for fecal incontinence and constipation [31][32][33][34] .…”
mentioning
confidence: 99%